Skip Nav Destination
Close
Article navigation
December 1987
Conference Abstract|
December 01 1987
Oxalate Retention in End-Stage Renal Failure (ESRF): Haemodialysis (HD) vs Chronic Ambulatory Peritoneal Dialysis (CAPD) and the Effects of Ascorbic Acid and Pyridoxine
S.H. Morgan
;
S.H. Morgan
1Clinical Research Centre, Harrow HA1 3UJ, UK
Search for other works by this author on:
P. Purkiss
;
P. Purkiss
1Clinical Research Centre, Harrow HA1 3UJ, UK
Search for other works by this author on:
E.R. Maher
;
E.R. Maher
∗Dept. Medicine, Charing Cross Hospital, London, UK
Search for other works by this author on:
R.W.E. Watts
;
R.W.E. Watts
1Clinical Research Centre, Harrow HA1 3UJ, UK
Search for other works by this author on:
J.R. Curtis
J.R. Curtis
∗Dept. Medicine, Charing Cross Hospital, London, UK
Search for other works by this author on:
Clin Sci (Lond) (1987) 73 (s17): 41P.
Citation
S.H. Morgan, P. Purkiss, E.R. Maher, R.W.E. Watts, J.R. Curtis; Oxalate Retention in End-Stage Renal Failure (ESRF): Haemodialysis (HD) vs Chronic Ambulatory Peritoneal Dialysis (CAPD) and the Effects of Ascorbic Acid and Pyridoxine. Clin Sci (Lond) 1 December 1987; 73 (s17): 41P. doi: https://doi.org/10.1042/cs073041Pc
Download citation file:
Close
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Cited By
Related Articles
Intracellular ion metabolism in erythrocytes and uraemia: The effect of different dialysis treatments
Clin Sci (Lond) (November,1986)
Skeletal muscle morphology and capillarization of renal failure patients receiving different dialysis therapies
Clin Sci (Lond) (November,2004)
Twenty-four hour hormonal and metabolic profiles in uraemic patients before and during treatment with continuous ambulatory peritoneal dialysis
Clin Sci (Lond) (October,1985)
Haemodialysis acutely reduces the plasma levels of ADMA without reversing impaired NO-dependent vasodilation
Clin Sci (Lond) (August,2009)